Home » Topics » Regulatory » Patents

Patents
RSS

New excitatory amino acid antagonists in development at Pfizer

Jan. 29, 1998

Inhibitors of the production or release of sCD23, TNF

Jan. 29, 1998

Dopamine D4 receptor antagonists for imaging and therapy disclosed by Janssen

Jan. 29, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Phenylglycine derivatives with mGluR-antagonist activity disclosed by Lilly

Jan. 28, 1998

Flavopiridol analogues as inhibitors of cyclin-dependent kinases

Jan. 28, 1998

Antitumor and antiviral distamycin derivatives from Pharmacia & Upjohn

Jan. 28, 1998

Indole endothelin antagonists prepared at Pfizer

Jan. 28, 1998

New AIDS therapies in development in Korea

Jan. 28, 1998

PKC modulators for proliferative disorders described by Georgetown U.

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.